Green fluorescent protein chromophore derivatives as a new class of aldose reductase inhibitors
Authors:
- 1 January 2017
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 125, 965-974
Abstract
No abstract availableKeywords
Funding Information
- JSPS KAKENHI (JP 25410179)
- Japan Society for the Promotion of Science
This publication has 63 references indexed in Scilit:
- The Polyol Pathway as a Mechanism for Diabetic Retinopathy: Attractive, Elusive, and ResilientJournal of Diabetes Research, 2007
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral NeuropathyDiabetes Care, 2001
- Diabetes complications and their potential prevention: Aldose reductase inhibition and other approachesMedicinal Research Reviews, 1999
- Clinical analysis of aldose reductase for differential diagnosis of the pathogenesis of diabetic complicationAnalytica Chimica Acta, 1998
- New aldose reductase inhibitors as potential agents for the prevention of long-term diabetic complicationsExpert Opinion on Therapeutic Patents, 1997
- Clinical Trials of Diabetic Neuropathy: Past, Present, and FutureDiabetes, 1995
- New approaches for treatment in diabetes: Aldose reductase inhibitorsBiomedicine & Pharmacotherapy, 1995
- Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complicationsJournal of Medicinal Chemistry, 1985
- Aldose reductase inhibition: Studies with alrestatinMetabolism, 1979